Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1992 | 03-1992 | 12-1991 | 06-1991 | 12-1990 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -710 | N/A | N/A | -256 | -256 |
| Depreciation Amortization | 5 | N/A | N/A | 2 | 2 |
| Other Working Capital | 64 | N/A | N/A | -36 | -36 |
| Other Operating Activity | 18 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-623 | $N/A | $N/A | $-289 | $-289 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | N/A | -3 | -3 |
| Other Investing Activity | 0 | 0 | 0 | 197 | 197 |
| Investing Cash Flow | $-9 | $N/A | $N/A | $194 | $194 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -25 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 5,327 | 0 | 0 | 182 | 182 |
| Financing Cash Flow | $5,302 | $N/A | $N/A | $182 | $182 |
| Beginning Cash Position | 87 | N/A | N/A | N/A | N/A |
| End Cash Position | 4,757 | N/A | N/A | 87 | 87 |
| Net Cash Flow | $4,670 | $N/A | $N/A | $87 | $87 |
| Free Cash Flow | |||||
| Operating Cash Flow | -623 | N/A | N/A | -289 | -289 |
| Free Cash Flow | -623 | 0 | 0 | -289 | -289 |